Statement by Mr. François Hollande, President of the Republic, on the fight against cancer, in Paris on December 4, 2012.

France François Hollande · President of France

4 December 2012 · Statement on the fight against cancer · Paris, France

Context
Hollande addressed health professionals and researchers in Paris on December 4, 2012, to announce France's third national cancer plan for 2014–2018.
Main themes
Cancer prevention and screening, national cancer plan 2014-2018, public health policy, cancer research and treatment progress, INCa, inequalities in healthcare, fight against smoking and alcoholism, cancer mortality and statistics, patient and family support, epidemiology, cancer care coordination
Duration
~20 min
66th percentile
Words
2,422
66th percentile
Sentences
140
78th percentile
Readability
50
62nd percentile
Grade
10.5
27th percentile
Syntax
2.71
14th percentile
Vocabulary
2.14
36th percentile

Translated from French

Content
Actors
Style

The broad sphere of national life a sentence belongs to. Every sentence has an Arena, so it is the denominator the other indices are read against.

Other
  • Social 75%73%
  • Institutional 15%14%
  • Ceremonial 7%7%
  • Economic 1%1%
  • Geopolitical 1%1%
  • Environmental 1%1%
  • Technological 0%0%
  • Not in focus 3%

140 sentences in 47 paragraphs

Ladies and gentlemen ministers,

Madam President of INCa,

Ladies and gentlemen directors,

Ladies and gentlemen,

I would like to first thank the rector of Paris for welcoming us to one of his many establishments and for giving an academic character to our meeting.

I am addressing you to talk about a subject where political speech is always imbued with gravity and humility when it touches on the most intimate, the most painful aspects of each of our lives. Cancer is one of those subjects.

The diagnosis, at the very moment it is formulated and revealed, disrupts the existence of the person to whom it is communicated, and the lives of their loved ones. It creates a before and an after the onset of the disease.

Five million families in France are confronted with this situation and know all of this. They know that cancer brings worry, uncertainty, and loneliness. But it also brings hope.

For this ordeal has now become one of duration. It can extend over years, during which remissions and anxieties follow one another.

A human, physical, psychological, and familial ordeal, cancer is also one of the greatest public health challenges for our country. It has become the leading cause of mortality in France.

Every year, more than 350,000 French people learn that they have cancer, and this number is steadily increasing. Every day, 1,000 new cases are detected. Every day, 500 people die from this disease in France.

Yet, for years, the efforts that have been made by many of those present in this room have borne fruit: in France, nearly 45% of cancers are cured. This is an encouragement for all those facing the disease, but also for all those who have combined their will and energy to reduce suffering and conquer the illness.

I want to acknowledge the mobilization of everyone: doctors, professionals, associations, and particularly the National League Against Cancer and the ARC Foundation for Research. These results are also due to the decisions made by the State over the past decades. I think of the National Cancer General States launched by Lionel Jospin, which prepared for the creation of the National Cancer Institute desired by Jacques Chirac in 2004.

INCa is now a unique structure that brings together and animates research, care, human sciences, and social sciences. It is considered - be proud of this, Madam President - as a model for Europe and a reference for other major pathologies affecting our fellow citizens. I want to commend the work of everyone, including you, Madam President, engaged in these efforts that you continue to lead, and today’s conference is proof of that.

Since 2003, two plans have succeeded each other - the second decided in 2008 by Nicolas Sarkozy - is soon coming to an end. I want to evaluate it.

First, to highlight the undeniable progress that has been made: the pooling of data and personnel, the creation of treatment guidelines, the rapprochement between research teams and care facilities, the establishment of regional molecular biology platforms and early-phase clinical trial centers. This is what has been achieved in our country over the years thanks to the actions of all within the framework of these two cancer plans.

But beyond these advances, the time for new decisions has come. Certainly, to consolidate achievements, but also to prepare us for the new challenges related to medical progress.

It is these advances that justify the existence of a third cancer plan 2014 - 2018, which I am announcing today. I have asked Mr. Jean-Paul VERNANT, Professor of Hematology at Pierre and Marie Curie University, to coordinate its preparation. It will be led by the two relevant ministries, the Ministry of Social Affairs and Health and the Ministry of Research. Its implementation will be ensured by INCa.

This plan will be organized around five major priorities that I have come here to present to you.

1. The first is prevention.

There is primary prevention, which relies on two major instruments: information and epidemiology. Information must be targeted to be effective. It will be. It will address the youngest populations, starting from school. I am particularly thinking of the fight against smoking and alcoholism, which are wounds all the more gaping as these habits begin early in life. Epidemiology contributes to detecting environmental or personal factors involved in the development of the disease. This instrument will be strengthened.

Then, there is what is called secondary prevention, in other words, screening. It remains very insufficient despite, once again, many efforts that have been made and initiated in recent years: only one in three people undergo screening for colon cancer, and only two out of three women for breast cancer. These campaigns will therefore be strengthened, and they will be all the more successful as the quality of diagnostics improves and they reach all social categories and all territories. Because, as you have demonstrated, inequalities are cumulative.

It is the most modest populations in the territories most affected by the crisis who are not only hit but also distanced from preventive measures, care centers, and sometimes even centers of excellence. To such an extent that the risk of dying from cancer between the ages of 30 and 65 is twice as high among workers as among professionals. This phenomenon has multiple causes, which we know: differences in access to information, risky practices, and finally exposure to toxic substances, which is the cause of many cancers. The plan will therefore include provisions to prevent occupational risks, through regional health at work schemes. It will also aim to reduce inequalities in information, screening, education, access to care, and treatments. The cancer plan will be a plan to combat inequalities.

2. The second priority is research.

Everyone understands that it is essential. Saying this is a given. But it must be comprehensive, starting from the identification of causes and continuing to the bedside of the patient and even beyond, once treatments are completed. To support it, the public authorities will pursue - within the framework of the third cancer plan - two objectives:

- The first objective is the development of personalized medicine, that is to say, medicine that refers to biology and selects the treatment best suited to the sick person. This choice is demanding. It requires the State to establish often very heavy technological infrastructures. In particular, high-throughput sequencing. This medicine also requires data storage facilities and the presence of highly qualified personnel. I am particularly thinking of bioinformaticians who must analyze and interpret the data.

- Research will also be directed towards another objective: that of closely linked research and care structures - I did not say grouped - and coordinated. Because if cancer research is done for the patient, it is also done with the patient. Patients are the actors of their own treatment. They must have access to innovative care. They must also, if they wish, participate in clinical trials. And here lies a considerable break from the past and from a number of our prejudices. I am pleased that over the past four years, the number of patients participating in these trials has increased by more than 60%. This is a testament to the advances in research; it is also proof that care and research can merge. It is also a demonstration that patients want to be involved in research that may concern them but can also bring benefits to others.

3. The third priority is care.

It is today disrupted by two major phenomena.

First, the aging of the population. With age, the frequency of cancer increases, but people live longer with cancer. Oncology will therefore increasingly address fragile subjects. And with the time gained thanks to treatments for the first cancer, a recurrence or a second cancer may sometimes occur many years later. There must therefore be prolonged follow-up for many years.

The second phenomenon is the mutation of therapies. The 20th century was that of surgery. The 21st century will be that of medicine and so-called "non-invasive" techniques, that is to say imaging, ultrasounds, but also innovative drugs, with chemotherapies administered orally. Access for all to quality care is therefore a priority. It is the quality of the initial care that will determine whether the future of each patient can be changed.

Cancer will thus become a chronic disease with care increasingly provided at home. Therefore, we must rethink the reception places for patients so that they are first multidisciplinary and articulated with city medicine; to involve the attending physician more in care outside the hospital. In a way, a revolution is taking place given the chronic nature of the disease and the fact that it can be treated outside hospital structures. We will therefore need to design a precise financing mechanism that can take into account, at their fair cost, outpatient activities in oncology and particularly innovative care. The third cancer plan will therefore integrate this dimension.

4. The fourth priority is training.

There have been advances in recent years, as I have pointed out, in all areas, particularly to increase the number of doctors specialized in oncology. And yet there are still too many shortcomings. It is therefore necessary to facilitate pathways between medical specialties. The Minister of Higher Education and Research will make proposals on this dual subject within the framework of the third cancer plan.

Training also applies to general practitioners, who will play an increasingly significant role in the follow-up and treatment of the disease. Support, follow-up, and essential dialogue with the surrounding community are all part of the vocation of the family doctor and the attending physician. As outpatient oncology medicine will have a greater place, the attending physician will also have an increasing role. It is therefore necessary, within the framework of medical training, to integrate this awareness of the situation of patients with cancer more than today. I commend the initiative taken by some universities to already develop teaching in the presence of patients and their families. For doctors, these examples can serve as a reference. They will not only be supported but also generalized. The future cancer plan will also be a training plan. Finally, oncology needs clinical nurses, whether they are care coordinators or home caregivers participating in the medical and psychological care of patients and their families. This is a new profession whose creation must be included in this new cancer plan.

5. Finally, the last priority is life during and after cancer.

Our objective - always in the spirit of fighting against inequalities - is to ensure, as the President of the League Against Cancer so aptly puts it, the continuity of life, particularly professional life.

An information campaign will therefore be launched by the Ministry of Labor on the resumption of activity for employees, whether they are sick or cured. This was measure 29 of the second cancer plan. It is high time to implement it.

Talking about the human and social consequences of a chronic disease like cancer means addressing not only accessibility to training and work but also the possibility of taking out loans or being covered by insurance. Because the most unbearable inequality is that which excludes sick or cured cancer patients from the places of life where they should be welcomed as a priority.

The last convention known as AERAS was signed on February 1, 2011. For several months, monitoring indicators for its provisions have been introduced, which is good. But this coverage must be further improved, based on an updated scientific assessment of risks. The results of the work will be known, I believe, during the year 2013. I will personally ensure, along with the government, that these conclusions can be translated into concrete life.

It is essential to respect the dignity of patients - we all say this - and therefore not to consider them as patients when they are no longer ill. Not as convalescents on hold, but as patients who must first be seen as valid and active citizens.

I know that, unfortunately, too many patients are children, victims of cancer as well. Here again, we must welcome more, improve support and follow-up, allow children affected by the disease to enter the hospital or their homes, while continuing their education at their school or, at the very least, benefiting from educational support. I would like to commend all those who dedicate themselves to this cause and who—often as volunteers—contribute day after day to the success of these children in their exams. Last year, nearly 1,500 children benefited from an individualized support project and just under 1,200 received home educational assistance. This is too little. Therefore, the third cancer plan—still in the spirit of fighting against inequalities at the youngest ages of life—will focus on facilitating the return to school for those who had to be absent to undergo treatment.

At all ages of a person's life—as well as at all moments in the life of a Nation—fighting against suffering, battling against evil and disease, ensuring that the person prevails over the patient, are causes that elevate us, that make us greater than we are, and that lead us to believe in human hope.

I know that here you dedicate your time, your work, and your talent to this great cause of fighting against cancer. With this third plan prepared throughout 2013 and implemented starting in 2014, the State will be by your side to provide the means for medicine to advance, for research to progress, for human dignity to prevail, so as not to add to the inevitable misfortunes of physical pain the avoidable tragedies of discrimination and injustice.

Together—I am convinced of this—the State, doctors, professionals, staff who dedicate themselves to health wherever they work, researchers, and the associations whose major role I do not forget—yes, together we can give patients, their families, and all the French who also worry for themselves by asking the question: “Can I too, in my turn, be affected by this evil?”—we can, through this mobilization, through this plan that is taking shape, through this gathering of all these energies, give reasons to fight and above all to hope.

Ladies and gentlemen, the strength of humanity is its ability to overcome evil by its own means, wherever it may be, wherever it is located, and whatever its causes may be. As long as we have this confidence in the resilience of humanity and are also aware of France's role, then fighting against cancer is not only our honor—yours—but above all our duty—the duty of the State.

Thank you.